Immucell Corp Stock Prediction
AI-powered sentiment analysis and prediction trends for ICCC, updated each market day.
ICCC AI Sentiment
AI sees no strong directional signal for Immucell Corp stock over the next 10 market days.
Prediction date: April 30, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Immucell Corp
ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.
Sector
Exchange
Market Cap
$72,374,392
Cap Tier
Employees
73
Headquarters
PORTLAND, ME
Listed Since
July 8, 1987
Website
ICCC Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
ICCC Volatility
Immucell Corp has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
